Literature DB >> 15084566

Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.

Michael P Frenneaux1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15084566      PMCID： PMC1768221          DOI： 10.1136/hrt.2003.020529

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  28 in total

Review 1.  Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

Authors:  William J McKenna; Elijah R Behr
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

2.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno Blanes; N G Mahon; J D Poloniecki; W J McKenna
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

3.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

4.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W K Shen; M S Link; A E Epstein; A K Almquist; J P Daubert; G H Bardy; S Favale; R F Rea; G Boriani; N A Estes; P Spirito
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest.

Authors:  F Cecchi; B J Maron; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

7.  Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

Authors:  V Dilsizian; R O Bonow; S E Epstein; L Fananapazir
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

9.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.

Authors:  Michael J Ackerman; Sara L VanDriest; Steve R Ommen; Melissa L Will; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

10.  Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Authors:  L Fananapazir; A C Chang; S E Epstein; D McAreavey
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690
View more
  12 in total

Review 1.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

Review 2.  Contemporary treatment of hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  Tex Heart Inst J       Date:  2009

3.  Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.

Authors:  Elsayed Z Soliman; Amit J Shah; Andrew Boerkircher; Yabing Li; Pentti M Rautaharju
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-04-24

4.  Treatment of athletes with cardiac disease or arrhythmias.

Authors:  Amil M Shah; N A Mark Estes; Jonathan Weinstock; Munther K Homoud; Mark S Link
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-09

5.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

6.  Hypertrophic cardiomyopathy: a new mutation illustrates the need for family-centered care.

Authors:  Daniel D Lee; Regan L Veith; David P Dimmock; Margaret M Samyn
Journal:  Pediatr Cardiol       Date:  2014-09-03       Impact factor: 1.655

Review 7.  Genetic counseling and testing for hypertrophic cardiomyopathy: an adult perspective.

Authors:  Cécile Skrzynia; Erin M Demo; Samantha M Baxter
Journal:  J Cardiovasc Transl Res       Date:  2009-09-26       Impact factor: 4.132

8.  Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Authors:  James R Peña; Ariani C Szkudlarek; Chad M Warren; Lynley S Heinrich; Robert D Gaffin; Ganapathy Jagatheesan; Federica del Monte; Roger J Hajjar; Paul H Goldspink; R John Solaro; David F Wieczorek; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-09-18       Impact factor: 5.000

9.  The role of echocardiography in the differential diagnosis between training induced myocardial hypertrophy versus cardiomyopathy.

Authors:  Tomas Venckunas; Birute Mazutaitiene
Journal:  J Sports Sci Med       Date:  2007-06-01       Impact factor: 2.988

10.  Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability.

Authors:  Giancarlo Todiere; Lorena Pisciella; Andrea Barison; Annamaria Del Franco; Elisabetta Zachara; Paolo Piaggi; Federica Re; Alessandro Pingitore; Michele Emdin; Massimo Lombardi; Giovanni Donato Aquaro
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.